Cargando…
Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
The overproduction of proinflammatory cytokines and subsequent thromboembolism are major problems of coronavirus disease 2019 (COVID-19). Adsorptive granulocyte and monocyte apheresis (GMA), used for ulcerative colitis, is an extracorporeal therapy designed to remove activated myeloid lineage cells....
Autores principales: | Kanekura, Takuro, Kawahara, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834290/ https://www.ncbi.nlm.nih.gov/pubmed/32721534 http://dx.doi.org/10.1016/j.ijid.2020.07.025 |
Ejemplares similares
-
Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017) -
Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats
por: Ma, Shuai, et al.
Publicado: (2017) -
Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022) -
Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
por: Fujii, Asami, et al.
Publicado: (2017) -
Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)